Lumos Pharma Inc (LUMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 12,474 | 28,711 | 28,711 | 68,501 | 172,592 |
| Gross Profit | 12,474 | 28,711 | 28,711 | 68,501 | 172,592 |
| Operating Expenses | 74,912 | 101,592 | 101,592 | 102,103 | 55,019 |
| Operating Income | -62,438 | -72,881 | -72,881 | -33,602 | 117,573 |
| Interest Expense | 52 | 119 | 119 | 105 | 26 |
| Other Income | 1,927 | 490 | 490 | 64 | 86 |
| Pre-tax Income | -60,563 | -72,510 | -72,510 | -33,643 | 117,633 |
| Income Tax | -6,968 | -559 | -559 | 6,738 | 21,616 |
| Net Income Continuous | -53,595 | -71,951 | -71,951 | -40,381 | 96,017 |
| Net Income | $-53,595 | $-71,951 | $-71,951 | $-40,381 | $96,017 |
| EPS Basic Total Ops | -12.96 | -20.70 | -20.70 | -12.69 | 31.05 |
| EPS Basic Continuous Ops | -12.97 | -20.69 | -20.69 | -12.71 | 31.04 |
| EPS Diluted Total Ops | -12.96 | -20.70 | -20.70 | -12.69 | 27.81 |
| EPS Diluted Continuous Ops | -12.97 | -20.69 | -20.69 | -12.71 | 27.86 |
| EPS Diluted Before Non-Recurring Items | -12.96 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-61,293 | $-71,474 | $-71,474 | $-32,010 | $118,670 |